In people with epilepsy, a new study has found a smartwatch application accurately detected tonic-clonic seizures, seizures ...

Findings revealed false alarm rates of 0.08 per 24 hours, equivalent to 1 false alarm every 12.4 days, with rates similar in all age groups.

The EpiWatch smartwatch app accurately detected 46 out of 47 tonic-clonic seizures – also known as grand mal seizures – among a group of people with epilepsy, researchers reported May 27 in the ...

Sudden unexpected death is a terrifying consequence faced by people living with uncontrolled tonic-clonic seizures (TCSs), so ...

In people with epilepsy, a new study has found a smartwatch application accurately detected tonic-clonic seizures, seizures ...

A smartwatch app detected epileptic tonic-clonic seizures with 98% accuracy and very low false alarms in a major clinical ...

Biohaven Ltd. (NYSE: BHVN), a global clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of life-changing therapies to treat a broad range of rare and ...

Shares of Biohaven advanced after the biopharmaceutical company reported new data from studies of its treatment for focal epilepsy. The stock rose 7.4%, to $10.15, midday Tuesday, but are still down ...

Discover high-conviction stock picks and new investing opportunities with the TipRanks Smart Investor Newsletter Biohaven Ltd. ( (BHVN)) has shared an update. On May 26, 2026, Biohaven reported new ...

Impaired consciousness has long been considered the hallmark of epileptic seizures. Both generalized seizures and complex partial seizures are characterized by a multifaceted spectrum of altered ...

Her experience is being shared by Epilepsy Action as part of its Missing Memories campaign for National Epilepsy Week.

NeuroPace, Inc. NPCE is tightening its focus on the core RNS franchise as it exits the DIXI distribution and leans into ...